News
2025
Dec 08
Monday, December 8, 2025
Dechra Announces FDA Approval of Emeprev™ (maropitant citrate) Injectable Solution
New bioequivalent provides veterinarians with an in-clinic antiemetic option to support patient relief from vomiting and helping to ensure clinical confidence
keyboard_arrow_right
Read more
2025
Nov 07
Friday, November 7, 2025
Dechra Advances Public Health as Newest Human-Animal Bond Certified Company
For International Human-Animal Bond Day (Nov. 8th), Dechra elevates its commitment to supporting veterinarians in protecting the bond worldwide
keyboard_arrow_right
Read more
2025
Nov 03
Monday, November 3, 2025
Dechra announces U.S. launch of Solovecin™ (cefovecin sodium), an in-clinic antibiotic solution for skin infections in dogs and cats
Ensures a full course of therapy in one, affordable injection, alleviating oral treatment compliance concerns
keyboard_arrow_right
Read more
2025
Sep 03
Wednesday, September 3, 2025
Dechra Expands AVMF Scholarship Program, Adding New Category Focused on Anesthesia, Surgery, and Critical Care
Over $60,000 in scholarships is now available to 20 veterinary students and 5 technicians.
keyboard_arrow_right
Read more
2025
Jun 20
Friday, June 20, 2025
On Take Your Dog to Work Day, HABRI and Dechra Partner to Strengthen the Human-Animal Bond
The Human Animal Bond Research Institute (HABRI) and Dechra, a global animal health company focused on veterinary specialty care, marked “Take Your Dog to Work Day” by announcing a new partnership to advance their shared mission of supporting the human-animal bond through research, education and advocacy.
keyboard_arrow_right
Read more
2025
May 13
Tuesday, May 13, 2025
Dechra Launches Catney® One: A New Tool for Feline Kidney Health
Catney One® provides veterinarians another option to combat phosphate absorption, a key challenge in maintaining feline kidney health
keyboard_arrow_right
Read more
2025
May 01
Thursday, May 1, 2025
Dechra Announces FDA Approval of Otiserene® (marbofloxacin, terbinafine, and dexamethasone otic suspension) the latest treatment for canine otitis externa
First single-dose, long-acting otitis externa product leveraging marbofloxacin
keyboard_arrow_right
Read more
2025
Apr 25
Friday, April 25, 2025
One More Step for Not One More Vet
This World Vet Day (April 26, 2025), Dechra – a leading global animal health company, launched its ‘One More Step for Not One More Vet’ campaign in its continued support of a veterinary mental health charity.
keyboard_arrow_right
Read more
2025
Mar 03
Monday, March 3, 2025
Dechra Launches DuOtic®: The First Antibiotic-Free Otitis Externa Treatment for Dogs
A first-to-market, antibiotic-free approach to treating canine ear infections with long-lasting relief and increased antimicrobial stewardship
keyboard_arrow_right
Read more
2025
Feb 19
Wednesday, February 19, 2025
Dechra Expands Commitment to Veterinary Profession with New American Veterinary Medical Foundation Scholarships
Nearly $50,000 in scholarships continues a decade-long effort of supporting veterinary students and now expands to veterinary technicians
keyboard_arrow_right
Read more